LSI Medience Corporation
↗Tokyo, Japan
LSI Medience Corporation is Japan's leading comprehensive healthcare services company headquartered in Tokyo. Founded in 1975 (originally as part of Mitsubishi Chemical), the company provides diversified healthcare solutions across clinical testing, diagnostics, and drug development support services. With approximately 3,500 consolidated employees, LSI Medience operates as a wholly-owned subsidiary of PHC Holdings Corporation (TSE: 6523). The company operates Japan's only WADA-accredited anti-doping laboratory and provides extensive clinical laboratory services to medical institutions nationwide. As part of strategic restructuring, LSI Medience transferred its drug development support business to Mediford Corporation (established November 1, 2023), a new PHC subsidiary that now provides comprehensive services from discovery through post-marketing surveillance.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:Clinical Laboratory Services, Healthcare Services
Sub-Industry:CRO, Clinical Diagnostics, Central Laboratory Services, Anti-Doping Analysis
SIZE & FINANCIALS
Employees:1001-5000
Revenue:¥95.6B - ¥103B (USD $676M - $731M) as of FY2023
Founded:1975
Ownership:subsidiary
Status:operating
FUNDING
Investors:PHC Holdings Corporation, KKR (indirectly via PHC Holdings - 38.3% stake)
CORPORATE STRUCTURE
Parent Company:PHC Holdings Corporation
Acquired By:PHC Holdings Corporation (2019-01-01)
Subsidiaries:Kyushu Pro Search Limited Liability Partnership (Research Support), Mediford Corporation (Drug Development - transferred Nov 1, 2023)
Key Partnerships:ACT Genomics (Genomic profiling partnership, July 2024), LabCorp Clinical Trials (Master Service Agreement for global central lab services, 2013), C2N Diagnostics (Alzheimer's research diagnostics, 2024), Marubeni Corporation & Metro Pacific Health (Philippine clinical lab expansion), Shimadzu Corporation (Anti-doping laboratory technology partnership)
COMPETITION
Position:Leader
Competitors:CMIC Group (CRO/CDMO services), Sofpromed (Clinical research services), Other Japanese CROs in Japan CRO Association
LEADERSHIP
Key Executives:
Not publicly disclosed - President & Chief Executive Officer
Scientific Founders:Mitsubishi Chemical (founding organization)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with LSI Medience Corporation. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.